Effect of Bushen Huoxue Prescription on Cognitive Dysfunction of KK-Ay Type 2 Diabetic Mice

Table 5

Determination of FINS, TC, and TG in each group at week 12 ( ± s, n = 10).

	FINS (ng/mL)	TC (mmol/L)	TG (mmol/L)	LDL-C (mmol/L)	HDL-C (mmol/L)
C57BL/6J	1.32 ± 0.67	1.39 ± 0.12	0.57 ± 0.12	0.31 ± 0.06	1.68 ± 0.30
KK-Ay	10.4 ± 2.31	3.55 ± 0.63	2.16±±0.44	0.50 ± 0.08	0.75 ± 0.13
KK-Ay + BSHX; 0.5 g/kg	9.25 ± 2.21	2.80 ± 0.88	1.62.39 ± 0.97	0.47 ± 0.09	0.78 ± 0.39
KK-Ay + BSHX; 1 g/kg	7.54 ± 1.43	3.07 ± 0.48	1.54 ± 0.41	0.44 ± 0.08	0.73 ± 0.22
KK-Ay + BSHX; 2 g/kg	8.58 ± 1.3	2.88 ± 0.85	1.36 ± 0.62	0.45 ± 0.04	1.30 ± 0.16
KK-Ay + Met; 250 mg/kg	6.52 ± 1.17	2.74 ± 0.90	1.6 ± 0.36	0.42 ± 0.05	0.80 ± 0.15

Data are expressed as mean ± SD (n = 10). , vs. the C57BL/6J group. , vs. the KK-Ay group.